" /> Ixazomib Citrate - CISMeF





Preferred Label : Ixazomib Citrate;

NCIt synonyms : 1,3,2-dioxaborinane-4-acetic acid, 4-carboxy-2-((1r)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-6-oxo-; Proteasome Inhibitor MLN9708;

NCIt definition : The citrate salt form of ixazomib, an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated.;

UNII : 46CWK97Z3K;

InChIKey : MBOMYENWWXQSNW-AWEZNQCLSA-N;

CAS number : 1239908-20-3;

Drug name : Ninlaro;

Molecule name : MLN-9708; MLN 9708;

Chemical formula : C20H23BCl2N2O9;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
10/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.